Special Awards
○ TOS Lifetime Achievement Award
Prior Recipients
2025Recipient
Li-Tzong Chen, MD, Ph.D.(陳立宗)
Chair Professor of Internal Medicine, College of Medicine, and Director of Center for Cancer Research, KMU, Kaohsiung, Taiwan
Co-affiliated, Investigator, National Institute of Cancer Research, NHRI.
2025Recipient
Li-Tzong Chen, MD, Ph.D.(陳立宗)
Chair Professor of Internal Medicine, College of Medicine, and Director of Center for Cancer Research, KMU, Kaohsiung, Taiwan
Co-affiliated, Investigator, National Institute of Cancer Research, NHRI.
EDUCATION and TRAINING:
1975.8 - 1982.7 M.D. Kaohsiung Medical College, Kaohsiung, Taiwan
1992.8 – 2001.7 Ph.D. Post-graduate School, Kaohsiung Medical University (KMU)
1988.04 - 1990.03 Fellowship of Medical Oncology Training Program Institute of Biomedical Science, Academia Sinica, Taipei
2005.09 – 2005.11 Visiting Scholar, Cancer Treatment Evaluation Program (CTEP), National Cancer Institute, National Institutes of Health, Bethesda, USA
HOSPITAL & ACADEMIC APPOINTMENTS:
1988.08 – Attending Physician, Division of Gastroenterology, Department of Medicine, Kaohsiung Medical University Hospital, Kaohsiung
1995.08 – Attending Physician, National Institute of Cancer Research, NHRI, Taiwan
1995.08 – 2007.07 National Taiwan University Hospital, Taipei
1995.08 – 2006.07 Veteran General Hospital, Taipei
2006.08 – 2007.07 Tri-service General Hospital, Taipei
2007.07 - National Cheng-Kung University Hospital, Tainan
2002.08 – 2012.08 Associate Investigator, National Institute of Cancer Research, NHRI.
2006.01 – 2014.07 Investigator, National Institute of Cancer Research, NHRI.
2008.03 – 2012.08 Deputy Director, National Institute of Cancer Research, NHRI.
2012.09 -2013.07 Vice Superintendent and Director of Cancer Centre, Kaohsiung Medical University Hospital, KMU, Kaohsiung, Taiwan
2013.08 –2014.07 Acting Director, National Institute of Cancer Research, NHRI.
2014.08 - 2021.07 Distinguished Investigator and Director, NHRI
2020.08 - Chair Professor of Internal Medicine, College of Medicine, and Director of Center for Cancer Research, KMU, Kaohsiung, Taiwan
2021.08 - Co-affiliated, Investigator, National Institute of Cancer Research, NHRI.
MAJOR RESEARCH INTERESTS:
1. Diagnosis, Treatment and Prognosis in Cancers of Digestive System.
2. Experimental Cancer Therapeutics and clinical trials
Awards / Honors
- 2003 Outstanding Clinical (徐千田) Research Award, Taiwan Oncology Society.
- 2010 Outstanding Research Achievement Award, National Health Research Institutes.
- 2014 Kobayashi Foundation Research Award, 11th international conference of Asia Clinical Oncology Society (ACOS).
- 2014 Outstanding Clinical Research Award, 24th 王民寧 Memorial Foundation.
- 2014&2017 Outstanding Research Award, Ministry of Science and Technology, Taiwan.
- 2015 Outstanding Research Award, Association of Kaohsiung Medical University Alumni.
- 2016 Outstanding Biomedical & Biotechnology Award, 李天德 Biomedical Foundation.
- 2017 Distinguished Award, 林炳文 Educational Foundation, Tainan, Taiwan.
- 2018 Gold Medal Award, Technology Transfer Award, 2018 BioTaipei Award, Bio@Taipei [施能耀、劉柯俊、陳立宗].
- 2019 6th National Industrial Innovation Award Innovative-Elite Award-Industrial Contribution (Individual Category), Ministry of Economic Affair, ROC.
- 2024 21st National Innovation Award in the Academic Research Category, the Research Center for Biotechnology and Medicine Policy [洪文俊、陳立宗、劉柯俊].
1. Chen LT, Yeh KH, Lin CW, Wang TE, Wang MC, Hsiao CF, Chen CC, Liou JM, Wang HP, Wei MF, Lee HW, Shun CT, Liu TW, Tien HF, Wu MS, Kuo
SH*, Cheng AL; Taiwan Cooperative Oncology Group. Multicenter prospective first-line Helicobacter pylori eradication for localized gastric "pure"
diffuse large B-cell lymphoma. Am J Hematol. 2025 Feb 6. doi: 10.1002/ajh.27624.
2. Chen LT*, Vogel A, Hsu C, Chen MH, Fang W, Pangarsa EA, Sharma A, Ikeda M, Park JO, Tan CK, Regala E, Tai D, Tanasanvimon S, Charoentum
C, Chee CE, Lui A, Sow J, Oh DY, Ueno M, Ramaswamy A, Jeo WS, Zhou J, Curigliano G, Yoshino T, Bai LY, Pentheroudakis G, Chiang NJ,
Cervantes A, Chen JS, Ducreux M. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients
with biliary tract cancer. ESMO Open. 2024 Aug;9(8):103647.
3. Cheng SM, Su YY, Chiang NJ, Wang CJ, Chao YJ, Huang CJ, Tsai HJ, Chen SH, Chang CY, Tsai CR, Li YJ, Yen CJ, Chuang SC, Chang JS, Shan
YS*, Hwang DY*, Chen LT*. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter
study in Taiwan. J Biomed Sci. 2024 Feb 13;31(1):21.
4. Chiang NJ, Tan KT, Bai LY, Hung YP, Hsiao CF, Huang CJ, Chen SC, Shan YS, Chao Y, Huang YH, Lee IC, Lee PC, Su YY, Chen SJ, Yeh CN, Chen
LT*, Chen MH*. Impaired chromatin remodeling predicts better survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract
cancer: a Phase II T1219 study. Clin Cancer Res 2022 Oct 3;28(19): 4248-4257
5. Kang YK, Chen LT, Ryu MH, Oh DY, Oh SC, H Chung HC, Lee KW, Omori T, Shitara K, Sakuramoto S, Chung IJ, Yamaguchi K, Kato K, Sym SJ,
Kadowaki S, Tsuji K, Chen JS, Bai LY, Oh SY, Choda Y, Yasui H, Takeuchi K, Hirashima Y, Hagihara S, Boku N*. Nivolumab plus S-1/capecitabine
plus oxaliplatin versus placebo plus S‑1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable advanced or recurrent
HER2-negative gastric/gastroesophageal junction cancer: a multi-centre, randomised, double-blind, phase 3 trial (ATTRACTION-4). Lancet
Oncol. 2022 Feb;23(2):234-247.
6. Chen LT*, Martinelli E, Cheng AL, Pentheroudakis G, Qin S, Bhattacharyya GS, Ikeda M, Lim HY, Ho CF, Choo SP, Ren Z, Malhotra H, Ueno M, Ryoo
BY, Kiang TC, Tai D, Vogel A, Cervantes A, Lu SN, Yen CJ, Huang YH, Chen SC, Hsu C, Shen YC, Tabernero J, Yen Y, Hsu CH, Yoshino T, Douillard
JY. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced hepatocellular
carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO. Ann Oncol 2020 Mar;31(3):334-351
2024Recipient
Ann-Lii Cheng, MD., PhD(鄭安理)
Chair Professor, National Taiwan University
President Emeritus, NTU Cancer Center
2024Recipient
Ann-Lii Cheng, MD., PhD(鄭安理)
Chair Professor, National Taiwan University
President Emeritus, NTU Cancer Center
Ann-Lii Cheng is NTU Chair professor and President Emeritus of the NTU Cancer Center of National Taiwan University. He received his MD degree, PhD degree, and his specialty training in internal medicine and medical oncology at the Medical School of the National Taiwan University. Dr. Cheng has actively involved in basic and translational research of hepatocellular carcinoma and published more than 450 peer-reviewed articles. He was elected as Fellow of American Association for the Advancement of Science (AAAS) in 2007. He served as president of the APPLE society in 2017-2019. He is the founding director (2013-2020), and currently President Emeritus of NTU Cancer Center. Dr. Cheng is a world leader in the clinical and translational research of hepatocellular carcinoma, and has contributed to all contemporary first-line treatment of advanced HCC.
2023Recipient
Su, Ih-Jen(蘇益仁)
2023Recipient
Su, Ih-Jen(蘇益仁)
PROFESSIONAL APPOINTMENT (現職，含英譯)
| 任職年 (起迄) | 職稱 | 所屬單位 |
| 2015-至今 | 講座教授 (Chair Professor) | 南臺科技大學生物與食品科技系 (Department of Biotechnology and Food Technology, Southern Taiwan University of Science and Technology) |
| 2018-至今 | 創辦人及主持人 (Founder) | 美力齡生醫股份有限公司 (Merry Life Biomedical Company, Ltd.) |
| 2018-至今 | 名譽研究員 (Emeritus Research Fellow) | 國家衛生研究院感疫所 (National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes) |
EDUCATION(學歷)
| 畢業年 | 學位 | 學校名稱/ 系所 |
| 1976 | 醫學士 | 國立台灣大學/醫學系 |
| 1988 | 博士 | 國立台灣大學/病理研究所 |
WORKING EXPERIENCE (經歷)
| 任職年 (起迄) | 職稱 | 所屬單位 |
| 1992-1994 | 教授 | 國立台灣大學醫學院病理學科 |
| 1995-2000 | 教授及病理科主任 | 國立成功大學醫學院 |
| 2002-2014 | 特聘研究員兼主任/所長 | 國家衛生研究院感疫所 |
| 2003-2004 | 局長 | 行政院衛生署疾病管制局 |
| 2009-2011 | 副院長 | 國立成功大學醫學院附設醫院 |
| 2011-2018 | 獨立董事 | 台灣神隆生技公司 |
MAJOR RESEARCH AREA(研究領域)
- 病毒相關癌症的致病原理 (Pathogenesis of Virus-associated human cancers)
- 新興感染症的防疫 (Control of emerging virus infections)
- 老化生物學及藥物的開發 (Aging biology and drug product development)
- 阿茲海默症的新藥開發 (Drug development for Alzheimer's disease)
PUBLICATION(In the nearest 5 years)(發表、出版物)
論文著作：共316篇 (SCI 298篇)
以下代表作為2019-2023年間發表：
- Su, I. J., Hsu, C. Y., Shen, S., Chao, P. K., Hsu, J. T. A., Hsueh, J. T., Liang, J. J., Hsu, Y. T., Shie, F. S. The Beneficial Effects of Combining Anti-Aβ Antibody NP106 and Curcumin Analog TML-6 on the Treatment of Alzheimer’s Disease in APP/PS1 Mice. International Journal of Molecular Sciences. 2022 Jan 5. doi: 10.3390/ijms23010556.
- Su, I. J., Chang, H. Y., Wang, H. C., Tsai, K. J. A curcumin analog exhibits multiple biologic effects on the pathogenesis of Alzheimer’s disease and improves behavior, inflammation, and β-amyloid accumulation in a mouse model. International journal of molecular sciences. 2020 Jul 30. doi: 10.3390/ijms21155459.
- Teng, C. F., Wu, H. C., Su, I. J., Jeng, L. B. Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma. Viruses. 2020 Aug 26. doi: 10.3390/v12090945
- Teng, C. F., Yu, C. H., Chang, H. Y., Hsieh, W. C., Wu, T. H., Lin, J. H., Wu, H. C., Jeng, L.B., Su, I. J. Chemopreventive effect of phytosomal curcumin on hepatitis B virus-related hepatocellular carcinoma in a transgenic mouse model. Scientific reports. 2019 Jul 17. doi: 10.1038/s41598-019-46891-5.
- Chen, P. L., Hu, A. Y. C., Lin, C. Y., Weng, T. C., Lai, C. C., Tseng, Y. F., Cheng, M. C., Chia, M. Y., Lin, W. C., Yeh, C. T., Su, I. J., Lee, M. S. Development of American-Lineage Influenza H5N2 Reassortant Vaccine Viruses for Pandemic Preparedness. Viruses. 2019 Jun 11. doi: 10.3390/v11060543.
2022Recipient
Kuang-Yao Chen, M.D.,Ph.D.(陳光耀)
Taipei Veterans General Hospital
學歷
1959 臺北國防醫學院醫學學士
1971 美國休士敦德州大學生物醫學科學研究院放射生物學博士
資格證明及榮譽
1969 美國放射醫學會放射治療專科醫師資格證書
1969 美國醫學協會傑出醫師獎證書(Certificate of appreciation by
American Medical Association)
1971 國際知識名人錄證書(Certificate of The International Who’s Who of
Intellectuals)
1978-1979 國際名人錄第4版(Biographic Information appeared in
Who’s Who in the World, 4th edition )
2001 美國醫學專家名錄(Biographic Information in 2001 American Board of
Medical Specialists Compendium Supplement, ABMS Research and
Education Foundation)
經歷
1997.7-至今 臺北榮民總醫院癌病中心顧問
2008.11-2014.3 三軍總醫院立體定位放射手術中心特約醫師
2011.4-至今 合富公司首席醫療顧問
2005.7-2009.6 合富公司首席醫療長
2004.5-至今 陶聲洋防癌基金會董事長
1975.7-1997.7 臺北榮民總醫院癌病中心主任
1975.9-2003 國立陽明大學臨床教授
1993.2-1999 中華放射腫瘤學會創會理事長
1971.10-1989.7 臺北國防醫學院放射醫學系主任
1967.7-1971.8 美國德州大學安德森癌中心研究員
1962.1-1967.6 1971-1975 國防醫學院物理醫學系助教、講師兼臺北榮民總
醫院放射治療科住院醫師、總醫師、主治醫師
1960.5-1961.12 陸軍總醫院放射科住院醫師
1959.5-1960.5 馬祖野戰醫院外科醫師
出版
超過235篇論文刊載於國內外科學期刊。
2021Recipient
HSIEH, Chang-Yao, M.D., M.SPH (謝長堯)
Emeritus of NTUMC
❖ Education & Training Background: ⎢ View full profile ⎢
1970-1972 Reseach Fellow, Microbiology, NAMRU-2(us Naval Medical Research unit.No.2), Taipei
1966-1970 Resident, Dept.of OBG, NTUH
1980 M.SPH, Epidemiology, univ. of Washington, Seattle, USA
1965 M.D., Nat.Taiwan univ. Med. College
❖ Emplyment History:
1983 Visiting Scientist, NIH(USA)
1981 Clinical Fellow, Cancer control Agency of British Columbia(CCABC), Vancouver, Canada
1972-2005 Visiting staff(V.S.), Dept.of OBG, NTUH
2020Recipient
Po-Min Chen, M.D., Ph.D. (陳博明)
Taipei Veterans General Hospital
❖ Education ⎢ View full profile ⎢
1962 - 1969 Taipei Medical College, Department of Medicine, Bachelor of Medicine
1972 - 1978 Okayama University (Japan), Department of Medicine, Doctor of Medical Science
1978 - 1980 Sapporo Medical College (Japan), Department of Pathology, Clinic Fellow
❖ Brief Chronology of Employment
2008- current Chair, Taiwan Clinical Oncology Research Foundation
2008 - 2009 Senior Medical Advisor, Taipei Veterans General Hospital
2008 - current Honorary Professor, National Yang-Ming University
2010 - current Senior Medical Consultant/Professor, Taipei Veterans General Hospital
❖ Awards
1989 Outstanding Research Award of National Science Council
1991 Chi-Shuen Tsou Medical Research Special Award
1997 Medical Research Award of the Chinese Medical Association
2011 Recipient, Taiwan Cancer Medical Care Lifetime Achievement Award (Taiwan Joint Cancer Conference)
2019Recipient
Fang-Ku P'eng, M.D. (彭芳谷)
Departments of Surgery, Medical Research, and Medicine, Taipei Veterans General Hospital
2019Recipient
Fang-Ku P'eng, M.D. (彭芳谷)
Departments of Surgery, Medical Research, and Medicine, Taipei Veterans General Hospital
❖ Present Appointments: ⎢ View full profile ⎢
Doctor with Contract, Taipei Veterans General Hospital
Professor, Department of Surgery, National Yang-Ming Uiversity School of Medicine
❖ Experience:
Vice President, National Yang-Ming Uinversity School of Medicine
Dean, Taipei Veterans General Hospital
❖ Fields of specialty:
(1) Surgical Oncology
(2) Organ Transplantation
(3) Hospital Management
2018Recipient
Mow-Ming Hsu, M.D.(徐茂銘)
Professor Emeritus, Department of Otolaryngology, College of Medicine, National Taiwan University
2018Recipient
Mow-Ming Hsu, M.D.(徐茂銘)
Professor Emeritus, Department of Otolaryngology, College of Medicine, National Taiwan University
❖ Education: ⎢ View full profile ⎢
1960 Graduated from College of Medicine, National Taiwan University
1991 Doctor in Medical Science, Tokyo Medical University, Japan
❖ Qualifications:
1960 M.B.(=M.D.in U.S.) National Taiwan University
1986 ENT Specialist
1987 Clinical Immunologist
1999 Clinical Oncologist
❖ Present Appointments:
Professor Emeritus, Department of Otolaryngology, College of Medicine, National Taiwan University
Visiting Staff, Department of Otolaryngology, National Taiwan University Hospital
Consultant, Far-Eastern Hospital / Cathey Hospital / Koo-Foundation Hospital
❖ Experience:
1961-1964 Resident, Department of Otolaryngology, National Taiwan University Hospital
1964-1968 ENT Specialist, Misurata Government Hospital, Kingdom of Libya, North Africa
1972-1973 Clinical fellow, Department of Otolaryngology and Maxillofacial Surgery, University of Iowa, USA
Sep, 1968-2001 Visiting Staff, Department of Otolaryngology, National Taiwan University Hospital
1971-1974 Lecturer, Department of Otolaryngology, College of Medicine, National Taiwan University
1974-1982 Associate Professor, ibid
1982-2001 Professor, ibid
1987-1993 Chairman, ibid
Sep, 2001 Professor Emeritus, National Taiwan University
❖ Publications:
Published more than 200 referred articles, among them, more than 120 articles about nasopharyngeal carcinoma (a common cancer in Taiwanese men).
Chief editor of two books in Otolaryngology (in Chinese).
Published more than 100 articles of educational materials in Chinese for ENT residents.
The writer of 16 chapters (in Chinese) in various books.
❖ Awards:
Distinguished Cancer Research Award 2000 (The Chinese Oncology Society).
The Best Contribution Award 2003 (Taiwan Otolaryngological Society).
The Whole Life Contribution Award 2015 (Taiwan Head and Neck Society).
Lifetime Achievement Award in Cancer Medicine 2018 (Taiwan Oncology Society).
2017Recipient
Chiu-Hwa Wang,M.D.(王秋華)
Division of Hematology,Department of Internal Medicine,National Taiwan University Hospital
2017Recipient
Chiu-Hwa Wang,M.D.(王秋華)
Division of Hematology,Department of Internal Medicine,National Taiwan University Hospital
2016Recipient
King-Jen Chang,M.D.,Ph.D(張金堅)
Consultant Doctor, Taiwan Adventist Hospital
❖ Education:
1965-1972 M.D. of Dept. of Medicine, Collage of Medicine, National Taiwan Univ., Taipei, Taiwan
1978-1982 Ph.D. of Institute of Clinical Medicine ,National Taiwan Univ., Taipei, Taiwan
1984-1985 Research Fellow of Memorial Sloan-Kettering Cancer Center, N.Y.(U.S.A.)
❖ Fields of specialty:
(1) Surgical Oncology
Esp. in the field of breast cancer and colorectal cancer surgery
(2) Tumor immunology
(3) Angiogenesis related research
❖ Clinical experience:
1973-1977 Surgical Resident, Dept. of Surg.,National Taiwan Univ.Hosp.
1977-1978 Attending Surgeon, Taipei Municipal Chung-Hsin Hosp.,Dept. of Surg
1979-1985 Attending Surgeon, Dept. of Surg.,Collage of Medicine, National Taiwan University
1984-1985 Research Fellow, Memorial Sloan-Kettering Cancer Center, N.Y. （U.S.A.）
1985-1991 Associate Professor, Dept. of Surg.,Collage of Medicine, National Taiwan University
1991-now Professor, Dept. of Surg.,Collage of Medicine, National Taiwan University
1993-1996 Vice Chairman, Dept. of Surg.,Collage of Medicine, National Taiwan University Hospital
1996-2002 Chairman, Dept. of Surgery,Collage of Medicine, National Taiwan University Hospital
2010-2015 Superintendent, Chung-Kang Branch,Cheng Ching Hospital
2015Recipient
Jacqueline Whang-Peng,M.D.(彭汪嘉康)
Academician,Academia Sinica, R.O.C.
❖ Education:
2009 The Honorary Doctorate Degree of Science, National Taiwan University
1989-1991 Fellow of Medical Oncology of Washington Hospital Center, Washington D.C., U.S.A
1956 M.D. of Medical College, National Taiwan University, R.O.C.
❖ Specialty:
Medical Oncology,Cancer Genetic
❖ Honors:
- Woman of the Year Award, ROC, 1968.
- Arthur Flemming Award, USA, 1971.
- Honor Award from Department of Health, Education and Welfare, USA, 1972.
- Member of Academia Sinica, ROC, 1984 to present.
- Member, Advisory Committee, Institute of Biomedical Sciences, Academia Sinica, 1985.
- Scientific Award & President, Chinese American Medical and Health Asso., USA, 1985.
- Scientific Award, Chinese American Medical Society of USA, 1989.
- Outstanding Scientific Award, Organization of Chinese Americans, USA, 1989.
- PHS Commendation Award, USA, 1989.
- Award for 1st L’OREAL Women for Science, Taiwan, 2008.
- Distinguished Investigator, Emeritus, National Health Research Institutes, Taiwan, 2008
- Honorary Doctor of Medicine, National Taiwan University, Taiwan, 2009
- The 2011 Reach to Recovery International Health Professional Medal, UICC, 2011
❖ Brief Chronology of Employment:
2014.10- Board Member, Development Center for Biotechnology (DCB)
2014.06- Member of the Board of Supervisors, Taiwan Genomics and Genetics Society
2014.06~ Board Member, The MJ Health Research Foundation (美兆集團)
2013.8.1.- Superintendent, International Taipei Cancer Center, Taipei Medical University, R.O.C.
2012 – now Certificate Approval Committee, Quality improvement of cancer service, HPA, MOWH
2012 – now Committee of Hepatitis and Liver Cancer Control and Prevention, MOWH
2012 – now Council Unit of Policy of Chinese Medicine Industries, Committee on Chinese Medicine and Pharmacy, MOWH
2012 – now Member of Council Unit of Science and Technology, MOWH
2011 – now Deputy member of Human Subject Research Ethics Committee, Academia Sinica
2011 – now Member, Council of Academia Sinica, R.O.C.
2011 – now Chair Professor & Associate Dean of Medical Science and Technology College, Taipei Medical University, R.O.C.
2010 – now General Director of Cancer Research Center, Taipei Medical University, R.O.C.
2009 – now Honorary Vice Superintendent of Shangho Hospital, R.O.C.
2009 – 2012 Director of Cancer Center, Shangho Hospital, R.O.C.
2008 – now Director of Cancer Center, Wan Fang Hospital, R.O.C.
2008 – now Physician , Hematology & Oncology, Wan Fang Hospital, R.O.C.
2008-2010 Vice Superintendent of Wan Fang Hospital, R.O.C.
2006-2007 Director, Institute of Cancer Research, NHRI, R.O.C.
1998- now Member, Atomic Energy Council, Executive Yuan, R.O.C.
1998- now Member, Academic Review Committee Ministry of Education, Executive Yuan,R.O.C.
1997- now Vice President, Formosa Cancer Foundation, R.O.C.
1996-2005 Director, Division of Cancer Research, NHRI, R.O.C.
1995- now Professor, Medical College, National Taiwan University, R.O.C.
1994- now Professor, National Defense Medical College, R.O.C
1994-1996 Director, Cancer Clinical Research Center, Institute of Biomedical Science, Academia Sinica, R.O.C.
1993- now Member, Council of Academia Sinica, Taipei, Taiwan, R.O.C.
1993- now Professor, Institute of Clinical Medicine, National Yang Ming Medical University,R.O.C.
1984- now Academician, Academia Sinica, Taipei, Taiwan, R.O.C.
1976-1993 Medical Director, Public Health Service, Chief, Cytogenetic Oncology Section, Medicine Branch, Clinical Oncology Program, DCT, NCI, NIH, USA
1973-1975 Medical Officer, Senior Investigator, Chief, Cytogenetic Oncology Section, Medicine Branch, Medical Oncology Area, NCI, NIH, USA
1968-1973 Medical Officer and Senior Investigator, Human Tumor Cell Biology Branch, Chemotherapy, Clinical Trials, NCI, NIH, USA
1963-1968 Visiting Scientist, Medicine Branch, Chemotherapy, Clinical Trials, NCI, NIH, USA
1961-1963 Associate in Visiting program, Medicine Branch, NCI, NIH, USA
1960-1961 Fellow in Visiting Program, Medicine Branch, NCI, NIH, USA
